Boston Scientificvs.Stryker
BSX vs SYK · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Stryker is about 1.9× larger than Boston Scientific by market cap; Boston Scientific trades at the lower P/E (18.7 vs 38.0); year to date, Stryker leads (−6.2% vs −53.0%).
Side by side
| BSX | SYK | |
|---|---|---|
| Market cap | $66.5B | $127B |
| Price | $44.77 | $329.78 |
| Today | −0.5% | +0.8% |
| Return YTD | −53.0% | −6.2% |
| Return 1Y | −56.9% | −16.5% |
| P/E | 18.7 | 38.0 |
| P/S | 3.2 | 5.0 |
| P/B | 2.6 | 5.5 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →StrykerSYK
American medtech company focused on orthopaedics, surgical equipment and robot-assisted surgery (Mako).
Full SYK profile →More comparisons in Medtech & devices
See where BSX and SYK sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →